284 related articles for article (PubMed ID: 33007327)
1. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Abraham RS; Marshall JM; Kuehn HS; Rueda CM; Gibbs A; Guider W; Stewart C; Rosenzweig SD; Wang H; Jean S; Peeples M; King T; Hunt WG; Honegger JR; Ramilo O; Mustillo PJ; Mejias A; Ardura MI; Shimamura M
J Allergy Clin Immunol; 2021 Feb; 147(2):532-544.e1. PubMed ID: 33007327
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic or relapsing COVID-19 in immunodeficiency.
Brown LK; Moran E; Goodman A; Baxendale H; Bermingham W; Buckland M; AbdulKhaliq I; Jarvis H; Hunter M; Karanam S; Patel A; Jenkins M; Robbins A; Khan S; Simpson T; Jolles S; Underwood J; Savic S; Richter A; Shields A; Brown M; Lowe DM
J Allergy Clin Immunol; 2022 Feb; 149(2):557-561.e1. PubMed ID: 34780850
[TBL] [Abstract][Full Text] [Related]
3. Remdesivir for the treatment of COVID-19.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
[TBL] [Abstract][Full Text] [Related]
4. Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer.
Knight TE
Biopreserv Biobank; 2020 Dec; 18(6):492-502. PubMed ID: 32726140
[TBL] [Abstract][Full Text] [Related]
5. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
[TBL] [Abstract][Full Text] [Related]
6. Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation.
Glueck OM; Liang X; Badell I; Wratil PR; Graf A; Krebs S; Blum H; Hellmuth JC; Scherer C; Hollaus A; Spaeth PM; Karakoc B; Fuchs T; Zimmermann J; Kauke T; Moosmann A; Keppler OT; Schneider C; Muenchhoff M
Infection; 2024 Jun; 52(3):847-855. PubMed ID: 37922037
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
9. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
Delorme-Axford E; Klionsky DJ
Autophagy; 2020 Dec; 16(12):2123-2127. PubMed ID: 33153403
[TBL] [Abstract][Full Text] [Related]
10. Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery.
Basheer M; Saad E; Laskar O; Schuster O; Rechnitzer H; Zisman-Rozen S; Azoulay D; Assy N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445605
[TBL] [Abstract][Full Text] [Related]
11. Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
Baang JH; Smith C; Mirabelli C; Valesano AL; Manthei DM; Bachman MA; Wobus CE; Adams M; Washer L; Martin ET; Lauring AS
J Infect Dis; 2021 Jan; 223(1):23-27. PubMed ID: 33089317
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
Maveddat A; Mallah H; Rao S; Ali K; Sherali S; Nugent K
Int J Occup Environ Med; 2020 Oct; 11(4):157-178. PubMed ID: 33098401
[TBL] [Abstract][Full Text] [Related]
13. Compassionate Use of Remdesivir in Children With Severe COVID-19.
Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A
Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243
[TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma.
Hopwood AJ; Jordan-Villegas A; Gutierrez LD; Cowart MC; Vega-Montalvo W; Cheung WL; McMahan MJ; Gomez MR; Laham FR
J Pediatric Infect Dis Soc; 2021 May; 10(5):691-694. PubMed ID: 33306130
[TBL] [Abstract][Full Text] [Related]
15. Case report study of the first five COVID-19 patients treated with remdesivir in France.
Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
[TBL] [Abstract][Full Text] [Related]
16. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
Front Immunol; 2019; 10():297. PubMed ID: 30941118
[TBL] [Abstract][Full Text] [Related]
18. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.
Contini C; Enrica Gallenga C; Neri G; Maritati M; Conti P
Med Hypotheses; 2020 Nov; 144():109876. PubMed ID: 32562915
[TBL] [Abstract][Full Text] [Related]
19. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
20. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]